124
Participants
Start Date
April 30, 2013
Primary Completion Date
May 31, 2015
Study Completion Date
December 31, 2015
Chidamide
Given orally
Paclitaxel
Given IV
Carboplatin
Given IV
Placebo
Given orally
The Second People's Hospital of Sichuan, Chengdu
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing
Beijing Chest Hospital, Capital Medical University, Beijing
The first Hospital of China Medical University, Shenyang
Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai
Jiangsu Cancer Hospital, Nanjing
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Hebei Provincial Tumor Hospital, Shijiazhuang
Lead Sponsor
Chipscreen Biosciences, Ltd.
INDUSTRY